Numa
Numa
Transforming high-density scientific biomarker data into an editorial, high-trust digital platform for decentralized clinical trials.
Brand Identity
Product Design
Development
UI Design
Research
Overview
Numa is a digital platform for decentralized clinical trials centered on collecting and analyzing motor biomarker data. Originating as a refined evolution of an earlier engagement with InDVI, the initiative serves as a core proof of capability for Teqqed—demonstrating our execution standard in architecting high-density scientific UI and complex clinical workflows without sacrificing clarity.
Approach
We approached the system through structured information architecture and precise visual calibration:
High-Precision Data Hierarchy: Organized raw biomarker streams into scannable telemetry modules and clean comparative states, cutting cognitive load for clinical researchers.
Editorial & Scientific Brand Language: Paired rigorous typography and tight grid structures with an understated palette, deliberately moving away from dated medical software aesthetics toward high-trust authority.
Multi-Surface Deliverables: Executed a high-converting Framer landing page tailored for waitlist acquisition, supported by technical LinkedIn data-visualization assets and comprehensive brand guidelines.
Challenge
Clinical trial interfaces often suffer from dense, fragmented data displays that alienate researchers and lower participant protocol compliance. The challenge was twofold: structuring high-frequency motor biomarker metrics into an instantly legible dashboard hierarchy, while establishing an uncompromising editorial visual identity that builds immediate credibility with pharmaceutical stakeholders and scientific investigators.
Outcome
Delivered a cohesive, end-to-end brand and digital presence that repositions decentralized motor trial software as modern, precise, and research-grade. The system successfully validates Teqqed’s capability to handle enterprise-grade scientific tooling while delivering an immediate platform for waitlist growth and stakeholder engagement.
